School of Public Health > News > Galvani to Receive Young Investigators' Prize


News

About the School
of Public Health

Admissions

Faculty directory

Academic programs

Research programs

Student Services

Ph.D. Graduate Program

Public Health Library

Alumni

News

Public Health Practice

Support the School

Calendar

Faculty and
Postdoctoral
Positions

Site directory

Contact us

Visiting Campus

Search

Faculty in the News

News Archives

Snapshots

Newsletter Archives

More News

Galvani to Receive Young Investigators' Prize from American Society of Naturalists

Alison Galvani photo.

Alison Galvani, Ph.D.

Alison Galvani, Ph.D., Assistant Professor in the Yale School of Public Health's Division of Epidemiology of Microbial Diseases, has been selected to receive a Young Investigators' Prize from the American Society of Naturalists (ASN). ASN, a prestigious group of evolutionary ecologists, publishes The American Naturalist, the leading journal in the field of evolutionary ecology. Young Investigators' Prizes recognize outstanding and promising work of investigators at an early career stage. Galvani will receive her award and present a paper entitled “Epidemiology Meets Evolutionary Ecology” at ASN's joint meeting with the Society for the Study of Evolution and the Society of Systematic Biologists, to be held from June 10 to 14 at the University of Alaska Fairbanks.

Galvani's research focuses on how evolutionary forces shape the engagement between infectious agents and the immune system of individual hosts, and, more generally, how evolution affects host-parasite (with parasite defined very broadly) interactions at the population level. In particular, she has shown that host and pathogen heterogeneity can have important repercussions for many aspects of the epidemiology and evolution of both populations, including the patterns of disease distribution, the intensity of competition between parasite strains, age-dependent profiles of infection intensity, and the evolution of virulence. Galvani has collaborated with Merck scientists to assess the public health impact of their human papillomavirus vaccine. She has also quantitatively evaluated the mechanism of progression from HIV to AIDS, and determined the historical selective pressures that acted on the HIV resistance allele CCR5-delta 32. Much of this work has direct implications for the potential success of different control policies and for the persistence of disease.

Yale University  |  Medical School Library  |  Yale School of Medicine Info |   EPH Administration (restricted)

Yale School of Public Health  |  60 College Street  |  P.O. Box 208034  |  New Haven, CT 06520.8034

Copyright © 2006, Yale School of Public Health, New Haven, Connecticut, USA.
All rights reserved. Comments or suggestions to site editor. Site designed by ITS-Med Web Design & Development.

Last modified: September 19, 2005 [LMc]